SCIENTIFIC BACKGROUND

AARS, ACTL6B, ADAM22, ADGRV1, ADRA2B, ALDH7A1, ALG13, AP3B2, ARHGEF15, ARHGEF9, ARV1, ARX, ATP1A2, BRAT1, CACNA1A, CACNA1E, CACNA1H, CACNB4, CAD, CASR, CDKL5, CERS1, CHD2, CHRNA2, CHRNA4, CHRNB2, CLCN2, CLCN4, CNPY3, CNTN2, CPA6, CPLX1, CSTB, CYFIP2, DCX, DENND5A, DEPDC5, DNM1, DOCK7, DYRK1A, EEF1A2, EFHC1, EPM2A, FGF12, FOXG1, FRRS1L, GABBR2, GABRA1, GABRA2, GABRA5, GABRB1, GABRB2, GABRB3, GABRD, GABRG2, GAL, GLS, GLUL, GNAO1, GOSR2, GPHN, GRIN2A, GRIN2B, GRIN2D, GUF1, HCN1, HDAC4, HNRNPU, IQSEC2, ITPA, KCNA1, KCNA2, KCNB1, KCNC1, KCNH5, KCNMA1, KCNQ2, KCNQ3, KCNT1, KCNT2, KCTD7, LGI1, LMNB2, MBD5, MDH2, MECP2, MEF2C, NECAP1, NEUROD2, NHLRC1, NPRL2, NPRL3, NTRK2, PARS2, PCDH19, PHACTR1, PIGA, PIGB, PIGP, PIGQ, PLCB1, PLPBP, PNKP, PNPO, POLG, PPP3CA, PRDM8, PRICKLE1, PRICKLE2, PRRT2, RANBP2, RANGAP1, RELN, RHOBTB2, RNF13, ROGDI, SCARB2, SCN1A, SCN1B, SCN2A, SCN3A, SCN8A, SCN9A, SIK1, SLC12A5, SLC13A5, SLC1A2, SLC25A12, SLC25A22, SLC2A1, SLC35A2, SLC6A1, SPTAN1, SRPX2, ST3GAL3, STX1B, STXBP1, SYNGAP1, SYNJ1, SZT2, TBC1D24, UBA5, WWOX, YWHAG

Epilepsies occur with a frequency of 0.5 to 1%, and almost half of them are begin in childhood. In the heterogeneous group of epilepsies at least 50% are genetically determined, and in most cases, caused by polygenic or multifactorial factors. Only 1 to 2% of so-called idiopathic epilepsies have monogenic inheritance. These include epileptic encephalopathies of childhood (EIEE), which start early in life, take on a severe course, are often difficult to treat and show comorbidities in addition to the existing cognitive development delay which is almost always present. In idiopathic generalized epilepsies, the detection of a pathogenic variant in one of the listed genes often indicates that there is an increased risk of developing epilepsy (known as susceptibility factors). A large proportion of hereditary epilepsies are caused by pathogenic variants in subunits of neuronal voltage-dependent sodium (Na+), potassium (K+), calcium (Ca2+) or chloride (Cl-) ion channels and subunits of ligand-dependent receptors such as the GABAA receptor and the nicotine acetyl choline receptor.

 

Genetic epilepsies can be compared with symptomatic epilepsies which occur as a consequence of a congenital brain malformation (e.g., migration disorder). They can also occur in the context of other genetic syndromes (e.g., Angelman syndrome, Rett syndrome, tuberous sclerosis) or in the case of chromosomal imbalances.

 

Clinical differential diagnosis can often be difficult, which is why genetic diagnostics—also by means of NGS—is becoming increasingly useful for clarifying the cause(s). The detection of a pathogenic variant can confirm a suspected diagnosis, which may lead to a targeted therapy (e.g., glucose transporter defect). In addition, further diagnostics can be avoided, and a prognostic assessment and statements on a possible risk of recurrence can be provided.

 

References

Myers et al. 2019, Clin Genet 95(1):95 / Scheffer et al. 2017, Epilepsia; 58(4):512 / Lesca et al. 2015, Rev Neurol (Paris) 6-7:539 / Poduri et al. 2014, Nat Rev Neurol 10(5):293 / Scheffer 2014, Neuropediatrics 45:70 / Thomas et al. 2014, Nat Rev Neurol 10:283 / Thomas et al. 2014, Nat Rev Neurol 10:283 / Hoppman-Chaney et al. 2012, Clin Genet 83:345 / Tavyev Asher et al. 2012, Eur J Med Genet 55:299 / Striano et al. 2012, Arch Neurol 69:322 / Noh et al. 2012, Eur J Med Genet 55:281 / Weber et al. 2011, Z Epileptol 24:100 / Nicita et al. 2011, Seizure 21:3 / Muhle et al. 2011, Epilepsia 52:e194 / Depienne et al. 2010, Hum Mut 32:E1959 / Berg et al. 2010, Akt Neurol 37:120 / OMIM, Online Mendelian Inheritance In Man

GENES

AARS, ACTL6B, ADAM22, ADGRV1, ADRA2B, ALDH7A1, ALG13, AP3B2, ARHGEF15, ARHGEF9, ARV1, ARX, ATP1A2, BRAT1, CACNA1A, CACNA1E, CACNA1H, CACNB4, CAD, CASR, CDKL5, CERS1, CHD2, CHRNA2, CHRNA4, CHRNB2, CLCN2, CLCN4, CNPY3, CNTN2, CPA6, CPLX1, CSTB, CYFIP2, DCX, DENND5A, DEPDC5, DNM1, DOCK7, DYRK1A, EEF1A2, EFHC1, EPM2A, FGF12, FOXG1, FRRS1L, GABBR2, GABRA1, GABRA2, GABRA5, GABRB1, GABRB2, GABRB3, GABRD, GABRG2, GAL, GLS, GLUL, GNAO1, GOSR2, GPHN, GRIN2A, GRIN2B, GRIN2D, GUF1, HCN1, HDAC4, HNRNPU, IQSEC2, ITPA, KCNA1, KCNA2, KCNB1, KCNC1, KCNH5, KCNMA1, KCNQ2, KCNQ3, KCNT1, KCNT2, KCTD7, LGI1, LMNB2, MBD5, MDH2, MECP2, MEF2C, NECAP1, NEUROD2, NHLRC1, NPRL2, NPRL3, NTRK2, PARS2, PCDH19, PHACTR1, PIGA, PIGB, PIGP, PIGQ, PLCB1, PLPBP, PNKP, PNPO, POLG, PPP3CA, PRDM8, PRICKLE1, PRICKLE2, PRRT2, RANBP2, RANGAP1, RELN, RHOBTB2, RNF13, ROGDI, SCARB2, SCN1A, SCN1B, SCN2A, SCN3A, SCN8A, SCN9A, SIK1, SLC12A5, SLC13A5, SLC1A2, SLC25A12, SLC25A22, SLC2A1, SLC35A2, SLC6A1, SPTAN1, SRPX2, ST3GAL3, STX1B, STXBP1, SYNGAP1, SYNJ1, SZT2, TBC1D24, UBA5, WWOX, YWHAG

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more